Alto Ingredients, Inc. (ALTO): Entry into a Material Definitive Agreement
Alto Ingredients, Inc. (ALTO) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 3 ea030067001ex10-1.htm AT-THE-MARKET ISSUANCE SALES AGREEMENT, DATED AS OF AUGUST 5, 2026, BY AND AMONG ALTO INGREDIENTS, INC., CRAIG-HALLUM CAPITAL GROUP LLC, THE BENCHMARK COMPANY, LLC AND H.C. WAINWRIGHT & CO., LLC Exhibit 10.1 ALTO INGREDIENTS, INC. Common Stock (par
How this was made
The 30-second read
Why it matters
An ATM facility enables sales “from time to time” up to a stated maximum offering price, which can pressure the stock if investors expect near-term dilution. However, the filing alone does not confirm any immediate issuance.
Market read
This is a fresh capital markets disclosure that can change dilution expectations, but it is not yet a confirmed share sale.
What to watch
Traders should watch for subsequent prospectus supplements or placement notices that specify actual share sale amounts, discount/premium to market, and any stated use of proceeds.
Background
The 8-K discloses ALTO’s entry into an ATM (at-the-market) equity issuance sales agreement with multiple agents, tied to an effective Form S-3 registration statement.
Ticker impact
ALTO entered an at-the-market issuance sales agreement allowing it to sell common stock up to $50 million via agents.
Near-term bias is typically negative-to-neutral due to dilution risk, with realized impact depending on actual share sales and pricing.
The filing discloses the structure and maximum aggregate offering price ($50M) but does not yet state any specific sale size, timing, or pricing.
Market effects
ATM equity issuance can be a read-through for financing conditions and dilution risk appetite in small-cap food/ingredient and specialty manufacturing.
No clear regional spillover indicated by the filing.
Limited global relevance; this is company-specific capital markets activity.
Counterpoint
If ALTO uses the ATM opportunistically at favorable prices, the program can reduce balance-sheet risk without a large immediate dilution overhang.
Key entities
- issuerAlto Ingredients, Inc.
Subject of the 8-K and counterparty to the ATM sales agreement.
- agentCraig-Hallum Capital Group LLC
Designated agent for sales under the ATM agreement.
- agentThe Benchmark Company, LLC
Agent under the ATM agreement.
- agentH.C. Wainwright & Co., LLC
Agent under the ATM agreement.
